Nymox Announces New Marketing Submission For NYMOZARFEX For BPH

Image Source: ©2022 Kalkine Media®

Dec 5 (Reuters) - Nymox Pharmaceutical Corp:

* NYMOX ANNOUNCES NEW MARKETING SUBMISSION FOR NYMOZARFEXâ„¢ FOR BPH

* NYMOX PHARMACEUTICAL CORP - ANNOUNCE A NEW FORMAL SUBMISSION HAS BEEN MADE IN EUROPE FOR FEXAPOTIDE TRIFLUTATE FOR TREATMENT BPH

* NYMOX PHARMACEUTICAL CORP - MARKETING AUTHORIZATION APPLICATION (MAA) WAS SUBMITTED TO DANISH AUTHORITIES Source text for Eikon: Further company coverage:



 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use on